SCHEDULE: Dauntless Investment Group Discloses OKYO Pharma Stake
Ownership Disclosure
Dauntless Investment Group, LLC reports a 1.17% passive ownership stake in OKYO Pharma Ltd. as of December 31, 2025.
Summary
- Dauntless Investment Group, LLC has filed an Amendment No. 3 to Schedule 13G regarding its beneficial ownership in OKYO Pharma Ltd.
- The filing indicates Dauntless Investment Group, LLC beneficially owns 471,523 shares of OKYO Pharma Ltd.'s common stock.
- This ownership represents 1.17% of the total class of securities.
- Dauntless Investment Group, LLC holds sole dispositive power over 360,352 shares and shared dispositive power over 111,171 shares.
- The reporting person is classified as a Single Family Office/Passive Investor.
- The securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. It is a standard disclosure of passive ownership and does not contain information that would inherently sway sentiment positively or negatively regarding the issuer's performance or prospects.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that this filing is a routine disclosure of passive ownership, common among institutional investors and family offices. It does not indicate any strategic shift or operational update for OKYO Pharma Ltd. but rather a transparency requirement for significant shareholders.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant passive investor's stake, confirming no intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires filing of this statement (reporting date for holdings) |
| 02/12/2026 | Signature date of the Schedule 13G filing |
Keywords
OKYO Pharma Ltd, Dauntless Investment Group, Schedule 13G, Beneficial Ownership, Passive Investment, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.